A U.S. jury on [March 27] awarded $81 million to a man who claimed his use of Bayer AG’s glyphosate-based weedkiller Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.
The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma. It awarded $5.9 million in compensatory and $75 million in punitive damages to Hardeman after finding that Roundup was defectively designed, that Monsanto failed to warn of the herbicide’s cancer risk and that the company acted negligently.
The verdict comes….after the same jury on March 19 found Roundup to have been a “substantial factor” in causing Hardeman’s cancer….Bayer shares fell more than 12 percent after last week’s jury finding.
In a statement released after the verdict, Bayer said….”This verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic….Bayer will appeal this verdict.”
Read full, original article: U.S. jury says Bayer must pay $81 million to man in Roundup cancer trial